MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
attributable to pavmed common...
-$6,988K
(-139.49%↓ Y/Y)
Less deemed dividend
on series c...
$6,689K
Less series b
convertible preferred stock...
$145K
Less series b
convertible preferred stock...
$94K
Net income (loss)
attributable to pavmed
-$60K
(-100.32%↓ Y/Y)
Net loss
attributable to the...
-$1,004K
(-191.01%↓ Y/Y)
Net income (loss)
before noncontrolling...
-$1,064K
(-105.71%↓ Y/Y)
Change in fair value -
senior secured...
-$3,360K
(-6957.14%↓ Y/Y)
Management fee income
$3,150K
(0.00%↑ Y/Y)
Change in fair value -
equity method...
$1,878K
(-91.06%↓ Y/Y)
Change in fair value -
warrant liability
-$1,831K
Grant income
$168K
(833.33%↑ Y/Y)
Change in fair value -
rights liability
$30K
Interest income
$19K
(137.50%↑ Y/Y)
Income (loss) before
provision for income tax
-$1,064K
(-105.71%↓ Y/Y)
Other income
(expense), net
$6,971K
(-71.04%↓ Y/Y)
Debt
extinguishments loss - senior...
-$3,422K
(-5800.00%↓ Y/Y)
Other expense
-$40K
Interest expense
$3K
(-25.00%↓ Y/Y)
Operating loss
-$8,035K
(-47.54%↓ Y/Y)
Revenue
$22K
(175.00%↑ Y/Y)
Total operating
expenses
$8,057K
(47.73%↑ Y/Y)
General and
administrative
$6,356K
(44.98%↑ Y/Y)
Research and development
$1,388K
(76.37%↑ Y/Y)
Sales and marketing
$216K
(-12.55%↓ Y/Y)
Cost of revenue
$97K
(169.44%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
PAVmed Inc. (PAVM)
PAVmed Inc. (PAVM)